Sarcopenia, Cerebral Palsy, and Botulinum Toxin Type A

JBJS Rev. 2019 Aug;7(8):e4. doi: 10.2106/JBJS.RVW.18.00153.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Botulinum Toxins, Type A / adverse effects*
  • Botulinum Toxins, Type A / therapeutic use
  • Cerebral Palsy* / complications
  • Cerebral Palsy* / physiopathology
  • Child
  • Disease Models, Animal
  • Humans
  • Muscle Spasticity / drug therapy
  • Muscle Spasticity / etiology
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / physiopathology
  • Rats
  • Sarcopenia* / chemically induced
  • Sarcopenia* / physiopathology

Substances

  • Botulinum Toxins, Type A